Molecular mechanisms of head and neck cancer

Marxa L. Figueiredo, Yong Kim, Xiaofeng C. Zhou, Jeffrey N. Myers, David D T Wong

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Head and neck squamous cell carcinoma (HNSCC) is the sixth most frequent cancer worldwide and the overall 50% five-year survival rate is among the lowest of the major cancers. Alterations in cellular molecules controlling DNA repair, proliferation, apoptosis, invasion and angiogenesis are known to contribute to the development of HNSCC. This review will focus on the molecular changes contributing to the pathogenesis of HNSCC and their clinical implications in designing new therapeutic strategies.

Original languageEnglish (US)
Pages (from-to)273-281
Number of pages9
JournalDrug Discovery Today: Disease Mechanisms
Volume1
Issue number2
DOIs
StatePublished - Nov 2004
Externally publishedYes

Fingerprint

Head and Neck Neoplasms
DNA Repair
Neoplasms
Apoptosis
Carcinoma, squamous cell of head and neck
Therapeutics

ASJC Scopus subject areas

  • Drug Discovery
  • Molecular Medicine

Cite this

Figueiredo, M. L., Kim, Y., Zhou, X. C., Myers, J. N., & Wong, D. D. T. (2004). Molecular mechanisms of head and neck cancer. Drug Discovery Today: Disease Mechanisms, 1(2), 273-281. https://doi.org/10.1016/j.ddmec.2004.10.003

Molecular mechanisms of head and neck cancer. / Figueiredo, Marxa L.; Kim, Yong; Zhou, Xiaofeng C.; Myers, Jeffrey N.; Wong, David D T.

In: Drug Discovery Today: Disease Mechanisms, Vol. 1, No. 2, 11.2004, p. 273-281.

Research output: Contribution to journalArticle

Figueiredo, ML, Kim, Y, Zhou, XC, Myers, JN & Wong, DDT 2004, 'Molecular mechanisms of head and neck cancer', Drug Discovery Today: Disease Mechanisms, vol. 1, no. 2, pp. 273-281. https://doi.org/10.1016/j.ddmec.2004.10.003
Figueiredo, Marxa L. ; Kim, Yong ; Zhou, Xiaofeng C. ; Myers, Jeffrey N. ; Wong, David D T. / Molecular mechanisms of head and neck cancer. In: Drug Discovery Today: Disease Mechanisms. 2004 ; Vol. 1, No. 2. pp. 273-281.
@article{74262e6e1e824ad7b662ad83b5b51ef9,
title = "Molecular mechanisms of head and neck cancer",
abstract = "Head and neck squamous cell carcinoma (HNSCC) is the sixth most frequent cancer worldwide and the overall 50{\%} five-year survival rate is among the lowest of the major cancers. Alterations in cellular molecules controlling DNA repair, proliferation, apoptosis, invasion and angiogenesis are known to contribute to the development of HNSCC. This review will focus on the molecular changes contributing to the pathogenesis of HNSCC and their clinical implications in designing new therapeutic strategies.",
author = "Figueiredo, {Marxa L.} and Yong Kim and Zhou, {Xiaofeng C.} and Myers, {Jeffrey N.} and Wong, {David D T}",
year = "2004",
month = "11",
doi = "10.1016/j.ddmec.2004.10.003",
language = "English (US)",
volume = "1",
pages = "273--281",
journal = "Drug Discovery Today: Disease Mechanisms",
issn = "1740-6765",
publisher = "Elsevier Limited",
number = "2",

}

TY - JOUR

T1 - Molecular mechanisms of head and neck cancer

AU - Figueiredo, Marxa L.

AU - Kim, Yong

AU - Zhou, Xiaofeng C.

AU - Myers, Jeffrey N.

AU - Wong, David D T

PY - 2004/11

Y1 - 2004/11

N2 - Head and neck squamous cell carcinoma (HNSCC) is the sixth most frequent cancer worldwide and the overall 50% five-year survival rate is among the lowest of the major cancers. Alterations in cellular molecules controlling DNA repair, proliferation, apoptosis, invasion and angiogenesis are known to contribute to the development of HNSCC. This review will focus on the molecular changes contributing to the pathogenesis of HNSCC and their clinical implications in designing new therapeutic strategies.

AB - Head and neck squamous cell carcinoma (HNSCC) is the sixth most frequent cancer worldwide and the overall 50% five-year survival rate is among the lowest of the major cancers. Alterations in cellular molecules controlling DNA repair, proliferation, apoptosis, invasion and angiogenesis are known to contribute to the development of HNSCC. This review will focus on the molecular changes contributing to the pathogenesis of HNSCC and their clinical implications in designing new therapeutic strategies.

UR - http://www.scopus.com/inward/record.url?scp=23744509484&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=23744509484&partnerID=8YFLogxK

U2 - 10.1016/j.ddmec.2004.10.003

DO - 10.1016/j.ddmec.2004.10.003

M3 - Article

VL - 1

SP - 273

EP - 281

JO - Drug Discovery Today: Disease Mechanisms

JF - Drug Discovery Today: Disease Mechanisms

SN - 1740-6765

IS - 2

ER -